Scientists Take Aim at Illicit Supply Chain Networks of Fake Medications

Presented by Office of Public Affairs and Communications

For many people in developing countries, the struggle for access to health care comes with a risk. Those patients can fall victim to falsified medications that fail to treat their conditions, with the potential to cause harm and, in some cases, death.

Now, a new study will take aim at illicit supply chain operations to improve detection of falsified medications before they harm patients. The project is a collaboration between the University of Notre Dame and Northwestern University.

The study is one of nine projects awarded funding through the National Science Foundation’s Early-Concept Grants for Exploratory Research (EAGER) focusing on disrupting illicit supply chain networks.